D. Rey

Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)*

Éric Rosenthal, Gilles Pialoux, N. Bernard et al. · Journal of Viral Hepatitis · 2006 · 139 citations

Medicine, Infectious Diseases, Internal Medicine +15

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

Chloe Orkin, Jean‐Michel Molina, Eugènia Negredo et al. · The Lancet HIV · 2017 · 96 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs

Clotilde Allavena, Cyrille Delpierre, Lise Cuzin et al. · Journal of Antimicrobial Chemotherapy · 2012 · 90 citations · Full text

Public Health, Infectious Diseases, Hiv Prevention +16

Increased Risk of Serious Bacterial Infections Due to Maternal Immunosuppression in HIV-Exposed Uninfected Infants in a European Country

Clément Taron-Brocard, Jérôme Le Chenadec, Albert Faye et al. · Clinical Infectious Diseases · 2014 · 87 citations · Full text

Public Health, Infectious Diseases, Maternal Health +17

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Slim Fourati, Charlotte Charpentier, Corinne Amiel et al. · Journal of Antimicrobial Chemotherapy · 2015 · 58 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17